sales@angenesci.com
Login | Register
logo
Structures Search
Home Sulfos 3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-(2-(1-methylpyrrolidin-2-yl)ethyl)-4-propoxybenzenesulfonamide

3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-(2-(1-methylpyrrolidin-2-yl)ethyl)-4-propoxybenzenesulfonamide

CAS No.:
268203-93-6
Catalog Number:
AG007MQF
Molecular Formula:
C25H36N6O4S
Molecular Weight:
516.6561
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
99%
1 week
United States
$207
- +
10mg
99%
1 week
United States
$307
- +
50mg
99%
1 week
United States
$973
- +
100mg
99%
1 week
United States
$1473
- +
Product Description
Catalog Number:
AG007MQF
Chemical Name:
3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-(2-(1-methylpyrrolidin-2-yl)ethyl)-4-propoxybenzenesulfonamide
CAS Number:
268203-93-6
Molecular Formula:
C25H36N6O4S
Molecular Weight:
516.6561
MDL Number:
MFCD20275557
IUPAC Name:
3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide
InChI:
InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)
InChI Key:
IYFNEFQTYQPVOC-UHFFFAOYSA-N
SMILES:
CCCOc1ccc(cc1c1nc2c(CCC)nn(c2c(=O)[nH]1)C)S(=O)(=O)NCCC1CCCN1C
Properties
Complexity:
894  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
516.252g/mol
Formal Charge:
0
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
516.661g/mol
Monoisotopic Mass:
516.252g/mol
Rotatable Bond Count:
11  
Topological Polar Surface Area:
126A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
3  
Literature
Title Journal
Chronic administration of udenafil, a selective phosphodiesterase type 5 inhibitor, promotes erectile function recovery in an animal model of bilateral cavernous nerve crush injury. The journal of sexual medicine 20110501
The contributions of cytochromes P450 3A4 and 3A5 to the metabolism of the phosphodiesterase type 5 inhibitors sildenafil, udenafil, and vardenafil. Drug metabolism and disposition: the biological fate of chemicals 20080601
Transport of a new erectogenic udenafil in Caco-2 cells. Archives of pharmacal research 20070901
DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats. Urology 20050101
Properties